GlassScriptPhysician profile
Alexander R Johnson
NPI 1568424406
$8,037.38
in general payments reported to CMS, 2019-2025
43 companies · $1,603 in 2025
The $1,603 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $722 · 2021: $1,442 · 2022: $1,223 · 2023: $1,250 · 2024: $713 · 2025: $1,603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,566.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $949.72 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $785.62 | 2019-2024 | Xarelto |
| Amgen INC. | $731.87 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $584.97 | 2019-2025 | Farxiga, Wainua |
| Pfizer INC. | $546.87 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $507.15 | 2021-2025 | Verquvo, Capvaxive |
| Heartflow, INC. | $439.52 | 2025 | |
| Boston Scientific Corporation | $424.34 | 2021-2025 | Farapulse, Watchman Access System |
| E.R. Squibb & Sons, L.L.C. | $368.13 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $358.75 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $298.27 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $292.36 | 2019-2024 | Lifevest |
| Cvrx, INC. | $262.78 | 2024-2025 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $198.26 | 2019-2023 | |
| Abbott Laboratories | $192.50 | 2019-2023 | Mitraclip, Cardiomems |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $163.77 | 2020-2025 | Nexletol |
| Edwards Lifesciences Corporation | $108.67 | 2020-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $85.58 | 2022-2025 | |
| Novo Nordisk INC | $64.52 | 2025 | Wegovy |
| Actelion Pharmaceuticals US, INC. | $56.92 | 2022-2024 | Uptravi, Opsumit |
| Regeneron Healthcare Solutions, INC. | $55.96 | 2019 | |
| Medtronic, INC. | $55.13 | 2021-2024 | Micra |
| Cleerly, INC. | $49.55 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Abiomed | $46.28 | 2022-2025 | |
| Corcept Therapeutics | $40.80 | 2025 | Korlym |
| Convatec INC. | $38.63 | 2025 | |
| Nuwellis, INC. | $36.14 | 2019 | |
| Alexion Pharmaceuticals, INC. | $31.62 | 2021-2022 | |
| Cardiva Medical, INC. | $24.84 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Impulse Dynamics (USA) INC. | $22.52 | 2024 | Optimizer |
| Altathera Pharmaceuticals LLC | $21.27 | 2023 | Sotalol Hydrochloride |
| Glaxosmithkline, LLC. | $20.96 | 2024 | Shingrix, Arexvy |
| Lantheus Medical Imaging, INC. | $20.57 | 2023 | Definity |
| Inspire Medical Systems, INC. | $20.45 | 2025 | Inspire |
| Portola Pharmaceuticals, LLC | $15.96 | 2019 | |
| Medtronic Vascular, INC. | $15.79 | 2020 | |
| Arbor Pharmaceuticals, INC. | $15.54 | 2020 | |
| Angiodynamics, INC. | $15.31 | 2025 | Angiovac |
| Kiniksa Pharmaceuticals, LTD. | $15.16 | 2023 | Arcalyst |
| Preventice Services, LLC | $14.45 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $13.54 | 2023 | Inpefa |
| Daiichi Sankyo INC. | $13.48 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.